Molecular Diagnostics for Ambiguous Melanocytic Tumors

Seminars in Cutaneous Medicine and Surgery

Volumn 31, Issue 4, 2012, Pages 274-278

  Shahbain, Hilmy ^a   Cooper, Chelsea ^b   Gerami, Pedram ^b  

^a BENEDICTINE UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

FISH; Fluorescence in situ hybridization; Melanoma; Spitz nevi; Spitz tumor

Indexed keywords

CANCER PROGNOSIS; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; JUVENILE MELANOMA; MELANOMA; MOLECULAR DIAGNOSIS; REVIEW;

COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MOLECULAR DIAGNOSTIC TECHNIQUES; NEVUS; NEVUS, EPITHELIOID AND SPINDLE CELL; PROGNOSIS; SKIN NEOPLASMS;

EID: 84869835676     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: 10.1016/j.sder.2012.09.001     Document Type: Review

References (39)

1. Barnhill R.L., Argenyi Z.B., From L., et al. Atypical Spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999, 30:513-520.
2. Gerami P., Barnhill R.L., Beilfuss B.A., et al. Superficial melanocytic neoplasms with pagetoid melanocytosis: A study of interobserver concordance and correlation with FISH. Am J Surg Pathol 2010, 34:816-821.
3. Barnhill R.L., Argenyi Z., Berwick M., et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): Lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol 2008, 32:36-44.
4. Clark W.H., Hood A.F., Tucker M.A., et al. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol 1998, 29:S1-S24.
5. Gerami P., Wass A., Mafee M., et al. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol 2009, 33:1783-1788.
6. Ludgate M.W., Fullen D.R., Lee J., et al. The atypical Spitz tumor of uncertain biologic potential: A series of 67 patients from a single institution. Cancer 2009, 115:631-641.
7. Zembowicz A., Carney J.A., Mihm M.C. Pigmented epithelioid melanocytoma: A low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004, 28:31-40.
8. Zembowicz A., Scolyer R.A. Nevus/melanocytoma/melanoma. An emerging paradigm for classification of melanocytic neoplasms?. Arch Pathol Lab Med 2011, 135:300-306.
9. Busam K.J., Murali R., Pulitzer M., et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 2009, 33:1386-1395.
10. Ghazi B., Carlson G.W., Murray D.R., et al. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Ann Surg Oncol 2010, 17:2471-2475.
11. Bastian B.C., LeBoit P.E., Hamm H., et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998, 58:2170-2175.
12. Bastian B.C., Olshen A.B., LeBoit P.E., et al. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003, 163:1765-1770.
13. Bastian B.C., Wesselmann U., Pinkel D., et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999, 113:1065-1069.
14. Bastian B.C., LeBoit P.E., Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000, 157:967-972.
15. Jensen D.E., Proctor M., Marquis S.T., et al. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998, 16:1097-1112.
16. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821.
17. Albertson D.G., Ylstra B., Segraves R., et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000, 25:144-146.
18. Bauer J., Bastian B.C. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: Comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 2006, 19:40-49.
19. Gerami P., Jewell S.S., Morrison L.E., et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009, 33:1146-1156.
20. Gerami P., Mafee M., Lurtsbarapa T., et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol 2010, 146:273-278.
21. Vergier B., Prochazkova-Carlotti M., de la Fouchardière A., et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol 2011, 24:613-623.
22. Busam K., Fang Y., Jhanwar S., et al. Distinction of conjuctival melanocytic nevi from melanoma by fluorescence In-situ hybridization. J Cutan Pathol 2010, 37:196-203.
23. Gerami P., Pouryazdanparast P., Vemula S., et al. Molecular analysis of a case of nevus of Ota progressing to melanoma with intermediate stages resembling cellular blue nevus. Am J Dermatopathol 2010, 32:301-305.
24. Pouryazdanparast P., Newman M., Mafee M., et al. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol 2009, 33:1396-1400.
25. Senetta R., Paglierani M., Massi D. Fluorescence in-situ hybridization analysis for melanoma diagnosis. Histopathology 2012, 60:706-714.
26. Gammon B., Beilfuss B., Guitart J., et al. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J Cutan Pathol 2011, 38:335-341.
27. Kapur P., Selim M.A., Roy L.C., et al. Spitz nevi and atypical Spitz nevi/tumors: A histologic and immunohistochemical analysis. Mod Pathol 2005, 18:197-204.
28. Lazzaro B., Elder D.E., Rebers A., et al. Immunophenotyping of compound and Spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. J Invest Dermatol 1993, 100:313S-317S.
29. Magro C.M., Yaniv S., Mihm M.C. The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: A distinct form of dysplastic Spitzoid nevomelanocytic proliferation. J Am Acad Dermatol 2009, 60:814-823.
30. Sepehr A., Chao E., Trefrey B., et al. Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol 2011, 147:1173-1179.
31. Gammon B., Beilfuss B., Guitart J., et al. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol 2012, 36:81-88.
32. Gerami P., Li G., Pouryazdanparast P., et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol 2012, 36:808-817.
33. Massi D., Cesinaro A.M., Tomasini C., et al. Atypical Spitzoid melanocytic tumors: A morphological, mutational, and FISH analysis. J Am Acad Dermatol 2011, 64:919-935.
34. Gaiser T., Kutzner H., Palmedo G., et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol 2010, 23:413-419.
35. Raskin L., Ludgate M., Iyer R.K., et al. Copy number variations and clinical outcome in atypical spitz tumors. Am J Surg Pathol 2011, 35:243-252.
36. North J.P., Vetto J.T., Murali R., et al. Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol 2011, 35:1146-1150.
37. Gerami P., Jewell S.S., Pouryazdanparast P., et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn 2011, 13:352-358.
38. Gerami P., Guitart J., Martini M., et al. Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: A possible indicator of aggressive behavior in melanomas. Arch Dermatol 2008, 144:1235-1236.
39. Gammon B., Ali L., Guitart J., et al. Homogeneous staining regions for cyclin d1, a marker of poor prognosis in malignant melanoma. Am J Dermatopathol 2012, 34:487-490.